Endeavor Health System and Children’s Hospital of Philadelphia (CHOP) were recently announced as the sites for two new CAIRIBU P20 FORWARD Centers.
The P20 FORWARD Center at Endeavor Health System will be led by PI Simon Hayward, PhD. The project is titled “Validating Mouse Models of Prostatic Hyperplasia,” and aims to address the need to generate a relevant mouse model for BPH. Early-stage investigator collaborators Petra Popovics, PhD (Virginia Health Sciences at Old Dominion), Nadia Lanman, PhD (Purdue University), and Renee Vickman, PhD (Endeavor Health) will work with Dr. Hayward to present a new mouse model to the scientific community.
The P20 FORWARD Center at CHOP will be led by PI Gregory Tasian, MD, MSc, MSCE. The “Personalizing Outcomes of Nephrolithiasis in Youth (PONY) P20 Center” aims to develop individualized management strategies for youth, aged 21 years and younger, with nephrolithiasis. They plan to generate new knowledge about 1) the natural history of non-obstructive kidney stones, and 2) the post-operative patient-reported experience following ureteroscopy surgery for stones. Early stage collaborators David Chu, MD, MSCE (Lurie Children’s Hospital in Chicago), Jonathan Ellison, MD (Children’s Wisconsin in Milwaukee) and Jing Huang, PhD (CHOP) will work with Dr. Tasian to generate new data regarding youth with nephrolithiasis.
The overall goal of the Fostering Research with Additional Resources and Development (FORWARD) Urology Centers program is to foster and expand the benign urology research community. Each site’s team will be comprised of junior investigators with at least one Early-Stage Investigator (ESI) and/or researcher new to urology. Research Project data are expected to facilitate at least one R01 grant application. Additionally, these Centers will be integrated into the CAIRIBU community, which will grant them access to many research resources as well as invaluable opportunities for collaboration.
These new sites will generate foundational knowledge that will be essential towards the treatment of both BPH and nephrolithiasis. They join currently funded CAIRIBU P20 FORWARD centers at Mayo Clinic Rochester (PIs, Kevin Koo, MD, MPH; John Lieske, MD) and Duke University (PI, Pei Zhong, PhD).
Congratulations to all the investigators!